Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07202611
What this trial is testing

DC/NK Cell Therapy

Who this might be right for
Lung Cancer (NSCLC)
National Taiwan University Clinical Trial Center 10
Not applicableNot Yet RecruitingNCT07652593
What this trial is testing

Interaction Between Decidual Cells and NK Cells in Endometriosis

Who this might be right for
Endometriosis
Hopital Foch 50
Early research (Phase 1)WithdrawnNCT04952584
What this trial is testing

Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma
Baylor College of Medicine
Not applicableUnknownNCT00692809
What this trial is testing

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Who this might be right for
Latent Tuberculosis InfectionHIV InfectionsTuberculosis
Ministry of Science and Technology, India 180
Very early researchUnknownNCT05215015
What this trial is testing

Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wuxi People's Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02489890
What this trial is testing

CIK in Treating Patients With Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
The First People's Hospital of Changzhou 1,500
Testing effectiveness (Phase 2)Study completedNCT03785925
What this trial is testing

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmNeoplasm Metastasis
Nektar Therapeutics 192
Early research (Phase 1)Study completedNCT01445561
What this trial is testing

Ultra Low Dose Interleukin-2 in Healthy Volunteers

Who this might be right for
Hematologic Diseases
National Heart, Lung, and Blood Institute (NHLBI) 22
Early research (Phase 1)Study completedNCT01212341
What this trial is testing

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

Who this might be right for
Malignant LymphomasSolid Tumors
Seoul National University Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06583083
What this trial is testing

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University 84
Not applicableStudy completedNCT00740337
What this trial is testing

Factors That Affect the Development of COPD Symptoms

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Washington University School of Medicine 82
Not applicableEnrolling By InvitationNCT06829836
What this trial is testing

Can You Breathe Your Way To Better Health?

Who this might be right for
CancerChronic StressAutonomic Dysfunction
University of Northern Colorado 36
Not applicableStudy completedNCT03859518
What this trial is testing

Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo

Who this might be right for
Vitiligo
Centre Hospitalier Universitaire de Nice 20
Not applicableUnknownNCT00173290
What this trial is testing

Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function

Who this might be right for
Cervical CancerBreast CancerEndometrial Cancer+1 more
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07510815
What this trial is testing

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Who this might be right for
Malignant Pleural Mesotheliomas
Beijing Biotech 36
Testing effectiveness (Phase 2)Looking for participantsNCT07635056
What this trial is testing

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Hospital Medical Center, Cincinnati 20
Testing effectiveness (Phase 2)UnknownNCT04414969
What this trial is testing

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Who this might be right for
Immune Checkpoint InhibitorChemotherapy EffectEpigenetic Disorder+1 more
Hunan Cancer Hospital 35
Early research (Phase 1)Looking for participantsNCT04848064
What this trial is testing

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Recurrent Adult T-Cell Leukemia/LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Adult T-Cell Leukemia/Lymphoma+1 more
John Reneau 12
Testing effectiveness (Phase 2)Looking for participantsNCT06710288
What this trial is testing

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
ImmunityBio, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT03002831
What this trial is testing

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Cancer
Henan Cancer Hospital 13
Next Page